Top 10 Biotechnology Angel Investors in Belgium in April 2025
A list of 10 angel investors that invest in Biotechnology startups based in Belgium. We rank investors based on the number of investments they made in Biotechnology companies from Belgium. We update this investor list every month.Top 10 Biotechnology Angel Investors in Belgium in April 2025
Investor | Biotechnology Belgium investments |
---|---|
Annie Vereecken | 3 |
Pierre Drion | 3 |
Luc Vauterin | 2 |
Evren Ucok | 1 |
Herman Verrelst | 1 |
Patrick Keereman | 1 |
Jean Dessain | 1 |
Yves Beudin | 1 |
Virginie Saverys | 1 |
Kenneth Buckfire | 1 |
Annie Vereecken
Show more
Investment focus
- Biotechnology, Medical, Hospital
- Seed, Series A, Funding Round
- Belgium
Portfolio highlights
- Ziphius — Ziphius Vaccines is a biopharmaceutical company dedicated to developing next-generation vaccines for the prevention of infectious diseases.
- Sensolus — Introducing our smart, industrial-grade tracking solution. With battery life of up to ten years, and no additional infrastructure needed.
- Allegro Biotech — Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).
Pierre Drion - CEO @ Petercam
Show more
Investment focus
- Biotechnology, Health Care, Life Science
- Series A, Series B, Funding Round
- Belgium
Portfolio highlights
- A-Mansia Biotech — A-Mansia Biotech is a developer of products based on the properties of the Akkermansia muciniphila (A. muciniphila) bacterium. The company's nutritional supplement based on a gut bacterium called Akkermansia, the population of microorganisms housed in the gastrointestinal tract. A. muciniphila is located in the mucus layer covering theintestinal epithelium, which allows the bacterium to establish a close cross-talk with the host.
- Novadip Biosciences — Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.
- Santero Therapeutics — This is the homepage of the website
Luc Vauterin - Board Member @ ONTOFORCE
Show more
Investment focus
- Life Science, Data Integration, Data Visualization
- Seed, Series A
- Belgium
Portfolio highlights
- ONTOFORCE — ONTOFORCE creates and implements pioneering semantic search technology for information management. Our user-friendly data search platform DISQOVER builds uniquely intelligent links between heterogeneous data sources, allowing everybody to become a data scientist.
Evren Ucok is a co-founder and investor at Peak Games, an interactive social game development platform.
He is also a partner at Earlybird Venture Capital, an investment fund-based in Europe that focuses on emerging companies; Trendyol.com, a fashion e-commerce site; and Oliver Wyman.
Show more
Investment focus
- Medical, Health Care, Life Science
- Series A
- Turkey, Belgium
Portfolio highlights
- idemama — Idemama is an online platform that provides its users with web and graphic design services. It is based in Istanbul, Turkey.
- Amyl Therapeutics — Amyl Therapeutics is a preclinical stage biotechnology company. Amyl Therapeutics uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-β(Aβ), Tau, and α-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases.
Herman Verrelst
Show more
Investment focus
- Medical, Hospital, Biotechnology
- Series A
- Belgium
Portfolio highlights
- UgenTec — FastFinder is intelligent software that automates sample workflow, ensures your assays are analyzed consistently and cuts data analysis time in half.
Patrick Keereman
Show more
Investment focus
- Medical, Hardware, Software
- Seed
- Belgium
Portfolio highlights
- MOLECUBES — MOLECUBES is a Ghent University spin-off started with the support of iMinds. Springing from the MEDISIP research group and the preclinical INFINITY lab, a team of young hardware and software engineers with hands-on experience grouped together to make a difference in their and your daily imaging practice.We build preclinical imaging cubesallowing you to combine SPECT, PET and CT imaging in almost any lab space. Modular systems leave full flexibility at your side while ensuring full mice and full rat imaging. Intuitive wireless acquisition and reconstruction software allow the systems to be used almost anywhere by anyone. Being built by end-users we also understand the importance of good servicing.
Jean Dessain - Non Executive Director @ OneLIFE
Show more
Investment focus
- Medical, Health Care, Biotechnology
- Angel
- Belgium
Portfolio highlights
- OneLIFE — Enzymatic cleaning solutions against soiling and biofilms for medical devices and the hospital environment. Safe for staff, patients and visitors.
Yves Beudin
Show more
Investment focus
- Medical, Health Care, Biotechnology
- Angel
- Belgium
Portfolio highlights
- OneLIFE — Enzymatic cleaning solutions against soiling and biofilms for medical devices and the hospital environment. Safe for staff, patients and visitors.
Virginie Saverys is a entrepreneur.
Show more
Investment focus
- Medical, Life Science, Biotechnology
- Seed
- Belgium
Portfolio highlights
- 4Tissue — Shaping the Future of Regenerative Medicine
Kenneth Buckfire is the Chief Executive Officer at Miller Buckfire.
Show more
Investment focus
- Medical, Health Care, Life Science
- Series A
- Belgium
Portfolio highlights
- Amyl Therapeutics — Amyl Therapeutics is a preclinical stage biotechnology company. Amyl Therapeutics uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-β(Aβ), Tau, and α-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases.
Investors by industry
Proptech
Impact
Hardware
Gaming
Google
Consumer
Energy
Climate
Marketplace
FinTech
Health Care
Community
Artificial intelligence
Biotech
EdTech
Sustainability
Organic Food
Venture Capital
Social Media
Real Estate
Android
Web3
Art
Big Data
Education
Finance
Digital Media
Video Games
Social Network
Franchise
Payments
Publishing
Construction
Food and Beverage
Financial Services
Retail
Clean Energy
B2B
Photography
Local
eSports
Legal
Enterprise Software
Internet
Sports
Medical
Email
Wellness
Music
Infrastructure
Beauty
Platforms
Mobile Advertising
Recruiting
Biotechnology
Hospitality
Cannabis
Fitness
Travel
Automotive
Wine And Spirits
Medical Device
Crowdfunding
Social
CleanTech
Mobile Apps
Transportation
InsurTech
Enterprise
LGBT
Manufacturing
Mobile
Theatre
Fashion
Oil and Gas
Film
Life Science
Non Profit
SaaS
Renewable Energy
Sporting Goods
Restaurants
Social Impact
Celebrity
Software
Cryptocurrency
Machine Learning
Blockchain
Agriculture (agtech)
Media (entertainment)
Facebook
Investors by country
Germany
United Kingdom
India
New Zealand
Canada
Ireland
Australia
United States
South Korea
China
Georgia
Ecuador
Bahrain
Faroe Islands
Belize
Egypt
Oceania
Croatia
Greece
Ghana
Hungary
Finland
Estonia
Costa Rica
Czech Republic
Ethiopia
France
Belgium
Hong Kong
Barbados
Gibraltar
Bermuda
Belarus
Algeria
Chile
Denmark
Bulgaria
Liberia
Kuwait
Peru
Japan
Myanmar
Liechtenstein
Morocco
Norway
Mexico
Panama
Lithuania
Sri Lanka
Nicaragua
Mali
Lebanon
Mauritius
Philippines
Israel
Jersey
Malaysia
Malta
Italy
Tajikistan
Togo
Seychelles
Poland
Zimbabwe
Tanzania
Puerto Rico
Serbia
Sweden
Senegal
Taiwan
Rwanda
Tunisia
Zambia
Slovenia
Sierra Leone
San Marino
Thailand
Uruguay
Portugal
Uzbekistan
Russian Federation
Turkey
El Salvador
Ukraine
Uganda
Venezuela
Dominican Republic
Namibia
Iceland
Azerbaijan
Nigeria
Bahamas
Iraq
United Arab Emirates
Jamaica
Honduras
Bolivia
Isle of Man
Luxembourg
Pakistan
Albania
Romania
Grenada
Singapore
Bangladesh
Argentina
Jordan
Europe
Indonesia
South Africa
Vietnam
Kazakhstan
Kenya
Cayman Islands
Cambodia
LATAM
Cyprus
Oman
Latvia
Spain
Armenia
Brazil
Africa
Middle East
Qatar
Asia
Saudi Arabia
Guatemala
Cameroon
Austria
Switzerland
Colombia
Marshall Islands
Angel Investors in Belgium by industry
Biotechnology
Marketplace
Food and Beverage
Financial Services
Big Data
Finance
Life Science
Medical
Medical Device
Internet
Social Media
Manufacturing
Software
Sports
Enterprise Software
Mobile Advertising
Hospitality
Automotive
FinTech
Enterprise
Health Care
Biotech
Climate
SaaS
Community
Gaming
Real Estate
Publishing
Transportation
Retail
Legal
Platforms
Payments
Proptech
Artificial intelligence
Hardware
Media (entertainment)
Construction
Machine Learning
Energy
Mobile